Ronnie T.P. Poon

15.0k total citations · 2 hit papers
106 papers, 8.4k citations indexed

About

Ronnie T.P. Poon is a scholar working on Hepatology, Molecular Biology and Oncology. According to data from OpenAlex, Ronnie T.P. Poon has authored 106 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Hepatology, 43 papers in Molecular Biology and 26 papers in Oncology. Recurrent topics in Ronnie T.P. Poon's work include Hepatocellular Carcinoma Treatment and Prognosis (49 papers), Cancer Mechanisms and Therapy (16 papers) and Liver Disease Diagnosis and Treatment (15 papers). Ronnie T.P. Poon is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (49 papers), Cancer Mechanisms and Therapy (16 papers) and Liver Disease Diagnosis and Treatment (15 papers). Ronnie T.P. Poon collaborates with scholars based in Hong Kong, China and United States. Ronnie T.P. Poon's co-authors include Sheung Tat Fan, Roberta Pang, Irene Oi‐Lin Ng, Kelvin K. Ng, Chung Mau Lo, Kwan Man, TP Ng, John M. Luk, Nicholas Borys and Thomas Yau and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nucleic Acids Research.

In The Last Decade

Ronnie T.P. Poon

106 papers receiving 8.3k citations

Hit Papers

Tumor Size Predicts Vascular Invasion and Histologic Grade 2005 2026 2012 2019 2005 2014 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tumor Size Predicts Vascular Invasion and Histologic Grade
    2005 511 citations Timothy M. Pawlik, Irene Oi‐Lin Ng et al. Liver Transplantation profile →
  2. Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
    2014 449 citations Andrew X. Zhu, Ronnie T.P. Poon et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronnie T.P. Poon Hong Kong 55 4.0k 3.1k 2.0k 2.0k 1.8k 106 8.4k
Louis Libbrecht Belgium 48 3.5k 0.9× 2.1k 0.7× 2.1k 1.0× 2.0k 1.0× 976 0.6× 170 7.5k
Charles Balabaud France 55 5.6k 1.4× 4.7k 1.5× 3.5k 1.7× 2.4k 1.2× 2.5k 1.4× 238 12.5k
Ronnie T.P. Poon Hong Kong 42 3.4k 0.8× 1.6k 0.5× 1.8k 0.9× 1.5k 0.8× 1.3k 0.7× 89 6.1k
Qing‐Hai Ye China 44 2.2k 0.5× 4.1k 1.4× 1.1k 0.5× 2.6k 1.3× 3.3k 1.9× 126 8.2k
Zhao–You Tang China 38 2.0k 0.5× 2.4k 0.8× 911 0.4× 1.5k 0.8× 1.8k 1.0× 164 5.7k
Shigeki Arii Japan 60 6.5k 1.6× 5.4k 1.8× 3.7k 1.8× 3.4k 1.7× 3.4k 1.9× 307 14.4k
Marshonna Forgues United States 36 2.0k 0.5× 5.5k 1.8× 1.3k 0.6× 2.5k 1.3× 3.9k 2.2× 51 9.4k
Daniela Sia United States 27 1.9k 0.5× 2.2k 0.7× 866 0.4× 1.7k 0.9× 1.8k 1.0× 50 5.5k
Jian Zhou China 39 1.8k 0.4× 2.5k 0.8× 863 0.4× 2.0k 1.0× 1.8k 1.0× 225 6.6k
Zhao–You Tang China 63 5.2k 1.3× 6.5k 2.1× 2.8k 1.4× 4.1k 2.1× 5.2k 3.0× 209 14.8k

Countries citing papers authored by Ronnie T.P. Poon

Since Specialization
Citations

This map shows the geographic impact of Ronnie T.P. Poon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronnie T.P. Poon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronnie T.P. Poon more than expected).

Fields of papers citing papers by Ronnie T.P. Poon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronnie T.P. Poon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronnie T.P. Poon. The network helps show where Ronnie T.P. Poon may publish in the future.

Co-authorship network of co-authors of Ronnie T.P. Poon

This figure shows the co-authorship network connecting the top 25 collaborators of Ronnie T.P. Poon. A scholar is included among the top collaborators of Ronnie T.P. Poon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronnie T.P. Poon. Ronnie T.P. Poon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yau, Thomas, Riccardo Lencioni, Wattana Sukeepaisarnjaroen, et al.. (2016). A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma. Clinical Cancer Research. 23(10). 2405–2413. 58 indexed citations
2.
Cheung, Phyllis F., Chi Wai Yip, Nicholas Wong, et al.. (2014). Granulin–Epithelin Precursor Renders Hepatocellular Carcinoma Cells Resistant to Natural Killer Cytotoxicity. Cancer Immunology Research. 2(12). 1209–1219. 37 indexed citations
3.
Fernandez-Banet, Julio, Nikki P. Lee, Kin Chan, et al.. (2014). Decoding complex patterns of genomic rearrangement in hepatocellular carcinoma. Genomics. 103(2-3). 189–203. 44 indexed citations
4.
Zhu, Andrew X., Darrell R. Borger, Yuhree Kim, et al.. (2014). Genomic Profiling of Intrahepatic Cholangiocarcinoma: Refining Prognosis and Identifying Therapeutic Targets. Annals of Surgical Oncology. 21(12). 3827–3834. 110 indexed citations
5.
Yeung, Oscar W.H., Chung Mau Lo, Qi Xiang, et al.. (2014). Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma. Journal of Hepatology. 62(3). 607–616. 332 indexed citations
6.
Pang, Roberta & Ronnie T.P. Poon. (2012). Cancer Stem Cell as a Potential Therapeutic Target in Hepatocellular Carcinoma. Current Cancer Drug Targets. 12(9). 1081–1094. 20 indexed citations
7.
8.
Wong, Hilda, Tzy‐Jyun Yao, Joanne Chiu, et al.. (2011). The Outcomes and Safety of Single-Agent Sorafenib in the Treatment of Elderly Patients with Advanced Hepatocellular Carcinoma (HCC). The Oncologist. 16(12). 1721–1728. 54 indexed citations
9.
Lü, Wenjing, Nikki P. Lee, Sunil C. Kaul, et al.. (2010). Induction of mutant p53‐dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin. International Journal of Cancer. 129(8). 1806–1814. 57 indexed citations
10.
Cheng, Qiao, TP Ng, Sheung Tat Fan, et al.. (2010). Distinct Mechanism of Small‐for‐Size Fatty Liver Graft Injury—Wnt4 Signaling Activates Hepatic Stellate Cells. American Journal of Transplantation. 10(5). 1178–1188. 23 indexed citations
11.
Lau, Chi Keung Marco, Zhen Yang, David Ho, et al.. (2009). An Akt/Hypoxia-Inducible Factor-1α/Platelet-Derived Growth Factor-BB Autocrine Loop Mediates Hypoxia-Induced Chemoresistance in Liver Cancer Cells and Tumorigenic Hepatic Progenitor Cells. Clinical Cancer Research. 15(10). 3462–3471. 94 indexed citations
12.
Tam, Ka Ho, Zhen Yang, Chi Keung Marco Lau, et al.. (2008). Inhibition of mTOR enhances chemosensitivity in hepatocellular carcinoma. Cancer Letters. 273(2). 201–209. 59 indexed citations
13.
Yau, Thomas, et al.. (2008). A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy. Cancer. 113(10). 2742–2751. 47 indexed citations
14.
Chan, Albert, Ronnie T.P. Poon, Kelvin K. Ng, et al.. (2008). Changing Paradigm in the Management of Hepatocellular Carcinoma Improves the Survival Benefit of Early Detection by Screening. Annals of Surgery. 247(4). 666–673. 76 indexed citations
15.
Sun, Chan, Kwan Man, TP Ng, et al.. (2008). Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation. Carcinogenesis. 29(11). 2096–2105. 94 indexed citations
16.
Ng, Kelvin K., Ksh Chok, Tan To Cheung, et al.. (2008). Risk Factors and Prognostic Factors of Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma. Journal of the American College of Surgeons. 207(1). 20–29. 147 indexed citations
17.
18.
Man, Kwan, TP Ng, Chung Mau Lo, et al.. (2007). Ischemia-Reperfusion of Small Liver Remnant Promotes Liver Tumor Growth and Metastases—Activation of Cell Invasion and Migration Pathways. Liver Transplantation. 13(12). 1669–1677. 111 indexed citations
19.
Hui, Chee‐Kin, Nancy Leung, Tony W.H. Shek, et al.. (2007). Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patients. Hepatology. 46(3). 690–698. 67 indexed citations
20.
Liu, Yuqing, Ronnie T.P. Poon, Jeremy Hughes, et al.. (2004). Chemokine receptors support infiltration of lymphocyte subpopulations in human hepatocellular carcinoma. Clinical Immunology. 114(2). 174–182. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louis Libbrecht Breakdown of academic impact, for papers by Charles Balabaud Breakdown of academic impact, for papers by Ronnie T.P. Poon Breakdown of academic impact, for papers by Qing‐Hai Ye Breakdown of academic impact, for papers by Zhao–You Tang Breakdown of academic impact, for papers by Shigeki Arii Breakdown of academic impact, for papers by Marshonna Forgues Breakdown of academic impact, for papers by Daniela Sia Breakdown of academic impact, for papers by Jian Zhou Breakdown of academic impact, for papers by Zhao–You Tang
Rankless by CCL
2026